Get the Weekly Intelligence Brief — top committee picks every Sunday.

BJ vs UTI

BJ's Wholesale Club vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
BJ
BJ's Wholesale Club
64
Buy
VS
UTI
Universal Technical Institute, Inc.
53
Watch
MetricBJUTI
AI Score 64 53
Price $93.94 $25.56
P/E Ratio 21.45× 40.60×
ROE 26.3% 19.2%
Revenue Growth YoY
Gross Margin 18.5% 61.5%
Debt / Equity 1.35× 1.04×
Dividend Yield 0.0% 0.0%
RSI (14) 54.8 20.6
Beta 0.225 1.236
Expected Upside +2.9%

AI Committee View

Current Innellis committee reasoning for BJ versus UTI.
BJ leads by 11 points.

BJ scores 64/100 (Buy) versus UTI at 53/100 (Watch).

BJ Committee View
50% agreement
6 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • ROE of 26.6% shows genuine earnings power backing the valuation — Value
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • Price-to-book of 5.5x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
  • Current ratio of 0.75 is tight -- limited short-term liquidity cushion — Risk
UTI Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • P/E of 37.4 is moderate-to-rich — Value
  • Price-to-book of 5.4x prices in significant intangible value — Value
  • EPS declining -25.9% YoY despite any revenue growth — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BJ Full Analysis UTI Full Analysis